Clinical trial
Agrylin Capsules 0.5 mg Drug Use-Result Survey
NCT03625895 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Agrylin Capsules 0.5 mg Drug Use-Result Survey
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 25, 2014
- Completion date
- March 11, 2021
- Enrollment
- 1,826 (actual)
- Sites
- 488
Conditions
As the registry lists them; a condition with its own page is linked.
essential thrombocythemia (et)